Drug repurposing: progress, challenges and recommendations
2018 · Nature Reviews Drug Discovery · 4,392 citations
https://doi.org/10.1038/nrd.2018.168
F
Francesco Iorio
Open Targets(GB)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
236
Papers
22.9K
Citations
46
h-index
93
i10-index
Francesco Iorio is an academic researcher from Open Targets. The author has contributed to research in topics: CRISPR and Genetic Engineering & Cancer Genomics and Diagnostics & Bioinformatics and Genomic Networks. The author has an h-index of 46, co-authored 201 publications.
ORCID: 0000-0001-7063-8913Papers by this author
worksA Landscape of Pharmacogenomic Interactions in Cancer
2016 · Cell · 2,158 citations
https://doi.org/10.1016/j.cell.2016.06.017
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
2019 · Nature · 1,339 citations
https://doi.org/10.1038/s41586-019-1103-9
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
2014 · Nature Communications · 890 citations
https://doi.org/10.1038/ncomms3997
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
2016 · Cell Reports · 784 citations
https://doi.org/10.1016/j.celrep.2016.09.079
Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening
2019 · Nature Communications · 128 citations
https://doi.org/10.1038/s41467-019-09940-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat